InvestorsHub Logo
icon url

drugmanrx

11/05/15 11:28 AM

#7175 RE: Fido #7174

Cost:

The average wage earner can not afford it, and the majority of people that need the treatment incomes are before the average wage earner.

Track record:

One or two case does not make a track record, insurance companies and the government are not going to pay for programs that say they work, Biocorrx needs to build a sucessful track record that shows it works.

Cost effective:

Biocorrx has to show that it treatment is more cost effective over the long haul than conventional treatments.

what's the holdup for acceptance of this program?



Biocorrx is selling a treatment not a drug, there are a lot of competing treatments out there that have been in place for quite sometime.

It is going to take awhile for Biocorrx to show that their treatment is superior and gain Insurance and government support.

If I were Biocorrx I would pick a section of a large city and offer a free clinic in that section to demonstrate to insurance companies and the government the impact my treatment would have on changing that community.